Cargando…
Low Molecular Weight Heparin in Portal Vein Thrombosis of Cirrhotic Patients: Only Therapeutic Purposes?
Cirrhosis has always been regarded as hemorrhagic coagulopathy caused by the reduction in the hepatic synthesis of procoagulant proteins. However, with the progression of liver disease, the cirrhotic patient undergoes a high rate of thrombotic phenomena in the portal venous system. Although the prog...
Autores principales: | Licinio, Raffaele, Principi, Mariabeatrice, Losurdo, Giuseppe, Castellaneta, Nicola Maurizio, Ierardi, Enzo, Di Leo, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295131/ https://www.ncbi.nlm.nih.gov/pubmed/25614899 http://dx.doi.org/10.1155/2014/895839 |
Ejemplares similares
-
A Prospective Trial in Saudi Arabia Comparing the 14-day Standard Triple Therapy with the 10-day Sequential Therapy for Treatment of Helicobacter pylori Infection: A Further Confirmation of “Geographic Weight”
por: Losurdo, Giuseppe, et al.
Publicado: (2016) -
Approach to different thrombolysis techniques and timing of thrombolysis in the management of portal vein thrombosis in cirrhotic patients
por: Primignani, Massimo, et al.
Publicado: (2023) -
Role of concomitant therapy for Helicobacter pylori eradication: A technical note
por: Losurdo, Giuseppe, et al.
Publicado: (2016) -
Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm
por: Losurdo, Giuseppe, et al.
Publicado: (2018) -
Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis
por: Losurdo, Giuseppe, et al.
Publicado: (2018)